COLL
Collegium Pharmaceutical Inc
$35.45
Earnings Summary
Revenue | $149.75Mn |
Net Profits | $31.94Mn |
Net Profit Margins | 21.33% |
Highlights
Collegium Pharmaceutical Inc’s revenue jumped 15.53% since last year same period to $149.75Mn in the Q4 2023. On a quarterly growth basis, Collegium Pharmaceutical Inc has generated 9.54% jump in its revenue since last 3-months.
Collegium Pharmaceutical Inc’s net profit jumped 543.67% since last year same period to $31.94Mn in the Q4 2023. On a quarterly growth basis, Collegium Pharmaceutical Inc has generated 54.79% jump in its net profits since last 3-months.
Collegium Pharmaceutical Inc’s net profit margin jumped 484.05% since last year same period to 21.33% in the Q4 2023. On a quarterly growth basis, Collegium Pharmaceutical Inc has generated 41.32% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Collegium Pharmaceutical Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.75 |
EPS Estimate Current Year | 0.75 |
Highlights
Collegium Pharmaceutical Inc’s earning per share (EPS) estimates for the current quarter stand at 0.75 - a 13.64% jump from last quarter’s estimates.
Collegium Pharmaceutical Inc’s earning per share (EPS) estimates for the current year stand at 0.75.
Key Ratios
Key ratios of the Collegium Pharmaceutical Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0.82 |
Highlights
Collegium Pharmaceutical Inc’s earning per share (EPS) jumped 490.48% since last year same period to 0.82 in the Q4 2023. This indicates that the Collegium Pharmaceutical Inc has generated 490.48% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-04 | 0.31 | -0.51 | -264.52% |
2023-11-07 | 0.52 | 0.53 | 1.92% |
2024-02-22 | 0.66 | 0.82 | 24.24% |
2023-08-03 | 0.29 | 0.34 | 17.24% |
₹0 US Stocks a/c Opening Fee